NCT04554849

Brief Summary

To study demographic characteristics of subjects referred to endocrine care for gender dysphoria and their psychosocial health

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 24, 2020

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 7, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 18, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

September 18, 2020

Status Verified

July 1, 2020

Enrollment Period

1.4 years

First QC Date

August 7, 2020

Last Update Submit

September 14, 2020

Conditions

Gender Dysphoria

Outcome Measures

Primary Outcomes (1)

  • Retrospective analysis of medical records

    Analysis of existing data

    2004-2020

Interventions

Gender dysphoria psychosocial healthOTHER

Retrospective analysis of medical records

Eligibility Criteria

Sexall(Gender-based eligibility)
Gender Eligibility DetailsSubjects who met diagnostic criteria for gender dysphoria (International Classification of Diseases 11th Revision. https://icdwhoint. 2018) and were seen regularly in the outpatient clinic at our department of endocrinology
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects who met diagnostic criteria for gender dysphoria (International Classification of Diseases 11th Revision. https://icdwhoint. 2018) and were seen regularly in the outpatient clinic at our department of endocrinology

You may not qualify if:

  • \- lack of data in the patients' records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU Nancy

Nancy, 54000, France

Location

MeSH Terms

Conditions

Gender Dysphoria

Condition Hierarchy (Ancestors)

Sexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2020

First Posted

September 18, 2020

Study Start

July 24, 2020

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

September 18, 2020

Record last verified: 2020-07

Locations

FR(1)